Brief: Aeterna Zentaris Reports Q3 2022 Financial Results
03/11/2022 12:27
Nov 3 (Reuters) - Aeterna Zentaris Inc AEZS.TO :
* AETERNA ZENTARIS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
* AETERNA ZENTARIS INC - QTRLY $0.70 LOSS PER COMMON SHARE
Source text for Eikon: ID:nGNX5PJPFs
Further company coverage: AEZS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on COSCIENS Biopharma
See all newsBrief: COSCIENS Acquires Nualtis Corp
Refile: Canada's COSCIENS Biopharma Q2 net loss narrows on higher sales
Canada's COSCIENS Biopharma Q1 net income turns positive on discontinued German operations
Brief: Cosciens Biopharma Inc Not Aware Of Material Undisclosed Information Amid Recent Trading Activity
Brief: Cosciens Provides Strategic Update